
BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …

GlaxoSmithKline is to invest £130 million in sub-Saharan Africa over the next five years – money which the company says …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

